Having trouble viewing this email? Click here
Weekly Digest of Events (4/2/2012 Update)
Dear Colleague,
Below please find the Massachusetts Life Sciences Center's weekly event
listings. New event titles since last week are in red. For the latest news visit our web
site at www.masslifesciences.com. Also, the Center is now on Twitter! See the link at
the bottom of this email to follow us on Twitter.
This week's listings include an expanded section on the upcoming BIO International
Convention in June. This section will grow as we get closer to the event. We are
happy to list any panels that have a Massachusetts connection - just send them my way
in the appropriate format for these listings.
If you are receiving this email as a forward, you can sign up to receive these emails
directly by using the "Join Our Mailing List" button at the bottom of this
message. Event sponsors are welcome to email me event information. We accept
event information up until 12:00 p.m. on Thursday to appear in the weekly listings the
following Monday.
-Angus
Angus G. McQuilken
Vice President for Communications
Massachusetts Life Sciences Center
Upcoming Application Deadlines:
No application deadlines are pending, however the Center has recently announced the
opening of applications for this year's Internship Challenge, the Center's flagship
workforce development program. Students, recent college graduates and companies
that may want to participate are encouraged to learn more here.
BIO International Convention:
The 2012 BIO International Convention will be held June 18-21 in Boston. Have you
registered to attend? You can learn more at http://convention.bio.org.
There is a volunteer program for the 2012 BIO International Convention. The
program has you work as a volunteer for 2 days and then attend for 2 days. There is an
online application process - first come, first served. Apply early!
http://bit.ly/uhOEuO #bio2012. Questions? [email protected]
BioSpace will host the BIO Career Fair on Monday, June 18th in Boston at the Hynes
Convention Center. Free to job seekers. If you are interested in a recruiting booth,
please reserve early. http://www.biocareerfair.org/
Digital BIO Brochure Links 2012 Highlights Brochure: featuring suggested itineraries, sponsors, super sessions,
BIO Exhibition overview, registration info, housing, schedule at a glance, and more
2012 Breakout Sessions Supplement: featuring descriptions and times of all confirmed
sessions
2012 Partnering Supplement: featuring "How to partner successfully", map,
testimonials, and more
Massachusetts-related sessions at BIO:
Orphan Disease Forum - Specialized Marketing & Sales: A Vision for Orphan
and Targeted Therapies When: Wednesday, June 20, 8:30 am - 9:45 am
Where: Room #209 at the Boston Convention and Exhibition Center
Website: http://mybio.zerista.com/event/member/46585#speakers
Donna LaVoie will moderate a panel at the 2012 BIO International Convention titled,
"Specialized Marketing & Sales: A Vision for Orphan and Targeted
Therapies." Biotech companies have paved the way for specialized marketing
approaches for orphan diseases since the early 1990s. Some companies have
developed life-changing therapies that truly change disease states. Today,
biotech/pharma leaders have jumped in. But can all companies large and small find
the focus for these orphan diseases and put the patient first? What are the obstacles
associated with creating a specialized marketing and sales effort for orphan drugs?
Gain critical understanding of how companies are employing specialized marketing
and sales approaches that are patient-centric.
Speakers on the panel include:
Kyle Brown Founder & CEO of Innolyst
Jayne Gershokowitz, Senior Director of Patient Advocacy & Public Policy of
Amicus Therapeutics
Mark Rothera, Global President of Aegerion Pharmaceuticals
Rogerio Vivaldi, SVP and Head of Rare Disease Business Unit of Genzyme
Using Systems Biology to "Fast-Track" Development and Approval of Novel
Therapeutics and Diagnostics When: Thursday, June 21st, 2012, 10:00 am - 11:30 am.
Where: Boston Convention & Exhibition Center
Overview of Systems Biology and how its application can determine more precisely
and quickly which biomarkers are relevant to specific diseases for diagnosis or
therapeutic intervention. This approach can also determine subgroups or different
genotypes within these diseases in developing a diagnostic test that will determine
whether a patient will respond to a specific drug with minimal side effects.
Drugs can now be targeted for a specific set of patients resulting in higher efficacy. In
return, the FDA requirements for the number of patients required for the phase I-III
trials may be smaller, the cost and time for R&D will be reduced and the approval time
will be shorter.
Moderator:
1) Regina Au, MBA, MIM - Principal, Strategic Marketing Consultant at
BioMarketing Insight
Speakers:
1) David E. Hill, PhD - Research Scientist in Cancer Biology and Associate Director
of the Center for Cancer Systems Biology (CCSB) at the Dana-Farber Cancer Institute
(DFCI).
2) Glenn Miller, PhD - Vice President / Head of Personalized Medicine, Astra Zeneca
3) Steven Tregay, PhD - Founder, President, and CEO of Forma Therapeutics
4) FDA Speaker - TBD
For details on the session and speakers go to
http://biomarketinginsight.com/Events.htm
MassChallenge:
Applications for the MassChallenge 2012 competition are now being accepted! You
can learn more about how to apply here. The Massachusetts Life Sciences Center is a
co-sponsor of MassChallenge.
Featured Events:
Global Trade Summit 2012 When: Tuesday, April 3, 2012 11:00 a.m.- 5:00 p.m.
Where: Brandies international Business School
Register: http://www.brandeis.edu/global/tradesmmit
Early Registration Fee: $65 (For members of AIM, MassBio, MassMEDIC, and other
cooperating organizations until March 15).
$90 others
This one-day conference is the premier Massachusetts event for professionals seeking
to understand and succeed in global markets. This program is designed to help
companies identify and take advantage of international business opportunities. This
year the Summit will focus on opportunities in emerging markets and will give special
attention to four countries: Brazil, India, Israel, and Turkey. Life Sciences Center VP
for Industry Relations & Programs Pamela Norton will participate in a panel on doing
business in Israel.
Keynote address by Governor Deval Patrick
There will also be more than 25 speakers in 8 sessions.
Followed by a reception.
MBI Networking Event When: April 5, 2012, 5:30-7:00 PM
Where: Gateway Park, 60 Prescott St., Worcester, MA 01605
Register: ADVANCED REGISTRATION IS REQUIRED at
http://www.wpiventureforum.org/netform.html
Keynote Introductions:
Kevin O'Sullivan: President and CEO, Massachusetts Biomedical Initiatives
(MBI)
Deirdre E. Sanders: Chair, WPI Venture Forum Executive Board
As winter moves behind us and summer beckons on the horizon it's time to shake off
the cold and spring into networking mode. The Worcester Polytechnic (WPI) Venture
Forum and the Massachusetts Biomedical Initiatives (MBI) will be holding our first
networking event of 2012 highlighting all that is life science. During the course of the
evening attendees will have the opportunity to connect with and learn about some of
the amazing science taking place at Gateway Park through short presentations by
researchers at the park. Attendees will also have an opportunity to tour the facility and
learn firsthand about the life science resources available in our own
backyard. Speakers for the evening include:
1. Justin Mih, Matrigen Life Technologies-Softwell: Transforming the Landscape of
Cell Structure
2. Christopher Lambert - Commercial Films: Opportunities in Surface Science
This will be an amazing evening of science, innovation, and networking. Event
registration is free and required with event sign-in beginning at 5:00 PM at Gateway
Park. Presentation and facilities tours will follow from 5:45 PM on and will be
ongoing throughout the evening. Light food and refreshments will be provided.
Networking reception brought to you by the WPI Venture Forum in partnership with
and sponsored by Gateway Park and the MBI - Life Science Innovation
Event co-sponsor - Mirick O'Connell attorneys at law.
MIT Enterprise Forum of Cambridge Presents "Robotics in Healthcare:
Solutions for the Hospital and Home" When: Wednesday, April 9, 2012 (Registration-5:30pm to 6:10pm, Program:-6:10pm-
8:00pm)
Where: MIT Stata Center, Room 32-123, 32 Vassar Street, Cambridge, MA 02139
Registration: http://www.mitforumcambridge.org/events/innovation-series-event-
robotics-in-healthcare-solutions-for-the-hospital-and-the-home/
Pricing: Forum members: $25, Non-members: $45. Students from all universities are
free with college ID. Pre-registration is encouraged.
Robotics hold the promise of addressing major healthcare issues in surgery,
diagnostics, prosthetics, physical and mental therapy, monitoring, and support. The
current challenge is for the industry to move beyond the hype cycle and into practical
applications that are used in the hospital, elder and rehabilitative care, and home
environments.
Where are advances being made to personalize care and improve the quality, access
and efficiency of healthcare through robotics? Our keynote speaker will be Colin
Angle, Chairman, CEO and Co-founder of iRobot. Angle's leadership has transformed
the MIT spin-off into a global leader of practical robots. He will share the advances
iRobot is making to develop automated home care and remote presence robots to
address the emerging global need to extend independent living for the aging
population.
The Early-Stage Life Sciences Technology Conference VIII When: Thursday, April 12, 2012, 1:00 - 7:00 PM
Where: Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115
Website: http://www.mattcenter.org/lsconf2012/home.html
Registration: https://quikpayasp.com/massachusetts/commerce_manager/payer.do?ord
erType=Early-Stage%20Life%20Sciences%20April%202012
The Early-Stage Life Sciences Technology Conference VIII is a showcase for platform
life sciences technologies developed at the universities, research institutions, and
hospitals of Massachusetts and for recently formed Massachusetts companies. The
Forum is an opportunity for these companies and researchers to present to an audience
of angel investors, venture capitalists and corporate investors. Companies that have
presented at the first seven Early Stage Life Sciences Conferences have raised over
$100 million in new investments.
MATTO members, academics/staff at MATTO member institutions, MassBio
members, Presenters, and Exhibitors - $95.00
Non-members - $140.00
Agenda
12:45 PM - 1:15 PM Registration and Dessert Bar
1:15 PM - 1:45 PM Welcome and Financing Panel
1:45 PM - 3:00 PM Company presentations - Session One
3:00 PM - 3:30 PM Coffee Break
3:30 PM - 5:00 PM Company presentations - Session Two
5:00 PM - 7:00 PM Networking Reception and Poster Session
Boston Biotech Business Development Conference 2012 When: April 17-18, 2012
Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston
Register: http://bbbiotechconference.com/conference-agenda.php?id=10
Current co-hosts include: Rich Aldrich, Josh Boger, Tony Coles, Michelle Dipp,
Samantha Du, Doug Fambrough, Colin Goddard, Sylvie Gregoire, Tuan Ha-Ngoc,
Peter Hecht, Mark Levin, John Maraganore, Lonnie Moulder, Richard Pops, George
Scangos, Henri Termeer, and Christoph Westphal.
The Boston Biotech Business Development Conference is a networking forum for
industry professionals offering exclusive access to the key decision makers who
influence deal making and investment in the life sciences. Attendees will gain insights
from presentations and panels featuring business development decision-makers from
several of the world's leading pharmaceutical and biotechnology companies, on the
current and future outlook for licensing, M&A and other business development
activities in the life sciences sector. In between learning what it takes to get a deal
done in biotech, the Business Development Conference offers opportunities
throughout the day to network one-on-one with the industry's top deal makers - senior
executives from biotech and pharma, leaders from Wall Street and venture capitalists.
8th Stem Cell Summit When: April 19-20, 2012
Where: Hyatt Harborside Hotel, 101 Harborside Drive, Boston
Register: http://www.gtcbio.com/stemcell
The 8th Stem Cell Summit provides cutting-edge information on developments in all
areas of the stem cell industry. research including the biology, medicine, applications,
regulations, and the business of Stem Cells. This summit includes two concurrent
tracks with one focused on the biology, medicine, and applications, and the other on
the technology and business of Stem Cells. Recent developments in pre-clinical and
clinical trials of stem cell therapy, regenerative medicine and tissue engineering,
cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem
cell research will be addressed. In addition, discussions will be led on business
opportunities, challenges, and potential success strategies.
Join in on the discussion and network with top executives from Sanofi-Aventis,
Athersys, Pfizer, Advanced Cell Therapeutics, Novartis, Viacyte, Baxter, Cytori
Therapeutics, Life Technologies, Fate Therapeutics, BioTime, Genzyme, Osiris,
Pleuristem, Harvard Stem Cell Institute, Massachusetts Life Sciences Center,
ReNeuron, SanBio, and many more!
BIOMEDevice Boston Conference When: April 25-26, 2012, 8:30 a.m. - 4:30 p.m.
Where: Boston Convention Center
Register: BIOMEDeviceForum.com
(Registration Fee: Call 310-996-9435 to receive 20% when you mention this
email!) Join your local peers to learn how world class innovators design and develop medical
devices - from concept to production. Medical technology professionals will find the
solutions and new ideas they need through a sequentially structured series of
interactive case studies, technology sessions, panel discussions and keynote
presentations.
Topics include:
* New innovative materials for the new or next generation devices
* Risk management in design
* Manufacturability and design transfer
* Innovation through progressive design & engineering strategies
* And more!
Translational Medicine Symposium: The Journey to Personalized Medicine When: Wednesday, May 23, 2012, 9:30 a.m.- 4:30 p.m.
Where: UK Trade & Investment, British Consulate-General, One Broadway,
Cambridge MA 02142
Register: http://www.idbs.com/events/translational-medicine-symposium-2012/
Fee: Complimentary
The success of Personalized Medicine relies on the joint efforts of hospitals, payers,
academic medical centers, pharmaceutical and diagnostic organizations. Our latest
forum for informed debate and lively discussion will take an in-depth look at all your
major informatics and analytics issues in translational medicine and biomarker
research. Topics will include, integration of Clinical, Omics, Research and Biobank
data, translational collaborations across sites and industry groups, Next Generation
Sequencing data management and analytics challenges, and clinical decision support
with Omics data.
Keynote speaker: Dr. Susan Windham-Bannister, President and CEO,
Massachusetts Life Sciences Center
John Quackenbush, Ph.D.
Professor of Computational Biology & Bioinformatics, Dana-Farber Cancer
Institute
Xinwei She, Ph.D.
Senior Research Scientist, Biological and Translational Informatics, Merck
Hai Hu, Ph. D.
Deputy Chief Scientific Officer Sr. Director of Biomedical Informatics,
Windber Research Institute
Paul Denny-Gouldson, Ph. D.
VP of Translational Medicine, IDBS
Complimentary event, followed by a reception. For more information please email
Aneta Manningtonova: [email protected]
3rd RNAi Research & Therapeutics Conference When: May 30-31, 2012
Where: Hyatt Harborside Hotel, 101 Harborside Drive, Boston
Register: http://www.gtcbio.com/rnai
GTC is proud to present our 3rd RNAi Research & Therapeutics Conference, which
will be held May 30-31, 2012 at the Hyatt Harborside in Boston, MA. We will bring
together industry leaders from major pharmaceutical companies, cutting-edge biotech
companies as well as top researchers from academia and government to present
innovative and relevant applications of current RNAi technologies to continually
improve efficacy and meaningful data output in drug discovery and development.
Topics of discussion include:
RNAi Delivery Methods
Gene Activation and Silencing by Small RNAs
Target Discovery and Validation
Therapeutic, Diagnostics and Clinical Applications
MicroRNA and Diseases
ncRNAs, lncRNA
Sign up for the RNAi Research and Therapeutics conference today!
Boston Biotech CEO Conference 2012 When: June 11-12, 2012
Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston
Register: http://bbbiotechconference.com/conference-agenda.php?id=11
(Please call reservations at the Mandarin Oriental Hotel today to book your
accommodations. Room Reservations: Telephone: +1 (617) 535 8880 or +1 (866) 526
6567)
Current co-hosts include: Rich Aldrich, Josh Boger, Tony Coles, Michelle Dipp,
Samantha Du, Doug Fambrough, Colin Goddard, Sylvie Gregoire, Tuan Ha-Ngoc,
Peter Hecht, Mark Levin, John Maraganore, Lonnie Moulder, Richard Pops, George
Scangos, Henri Termeer, and Christoph Westphal.
The Boston Biotech CEO Conference is an exclusive networking forum for industry
CEOs offering access to the key decision makers in the life sciences. Attendees will
gain insights from presentations and panels featuring CEOs from several of the world's
leading pharmaceutical and biotechnology companies, industry leaders in venture
capital, strategic consulting and private equity also participate each year. The CEO
Conference offers opportunities throughout the day to network one-on-one with the
industry's top deal makers - senior executives from biotech and pharma, leaders from
Wall Street and venture capitalists.
Save the Date: Prostate Cancer Awareness Day at the State House When: June 28, 2012, 10:00 a.m.-2:00 p.m.
Where: Great Hall, Massachusetts State House
RSVP: [email protected]
Prostate Cancer Awareness Day, organized each year by the AdMeTech Foundation,
seeks to raise awareness about prostate cancer and the imprtance of screening and
early detection. The program will feature elected officials, advocates and leading
researchers.
U.S. Senator Scott Brown, Senate President Therese Murray and State Representative
Benjamin Swan are scheduled to participate. The Massachusetts Life Sciences Center
is a co-sponsor of this year's event.
Other Upcoming Events:
Science & Jazz for Heart Stem Cell Therapies When: Monday, April 2, 2012
Where: Seminar - Harvard University Biological Laboratories, 16 Divinity Ave.
Concert:- Queen's Head Pub 45 Quincy St., Memorial Hall, lower level
The Consulates General of Germany in San Francisco and Boston are very pleased to
announce a series of biomedical seminars with special emphasis on translational
medicine in cardiology--seasoned with a dash of contemporary Jazz music. The
Harvard Stem Cell Institute, The Consulate General of Germany, and the Longwood
Symphony Orchestracordially invite you to:
4:00 PM Seminar: Current advances in cardiac regenerative therapies in the U.S. and
Germany Dr. Brock Reeve, Harvard Medical School Dr. Gustav Steinhoff, University
of Rostock
6:00 PM Concert: Jazz at Heart and members of the Longwood Symphony
Orchestra featuring: Dr. Gustav Steinhoff (piano), Dr. Christina Jaschkowiak
(vocals), Dr. Len Zon, LSO (trumpet), Dr. Wolfram Goessling, LSO (trumpet)
Sponsored by the Lufthansa Patient Mobility Program
This event is free and open to the public!
Key Patent Strategies for Medical Device Companies in 2012 When: April 3, 2012, 8:00am - 10:30am
Where: Mass. Medical Society, 860 Winter St, Waltham, MA 02451
Register: http://www.massmedic.com/register/key-patent-strategies-for-medical-
device-companies-in-2012/
This program will focus on how changes enacted in the America Invents Act (patent
reform) and major court decisions affect patent portfolio management and litigation
strategies in order to maximize value your companies' medical device patents. Among
the topics to be discussed are:
Fashioning patent prosecution strategies, including amendments and
continuation applications, that provide coverage over competitive products;
Coordinating among legal, R&D, marketing and business development to
inform the drafting of patent claims;
Developing patent litigation strategies that maximize long term value of a
product line and company franchise without risking your patent portfolio.
Member Cost: $50
Nonmember Cost: $85
MDG April Forum When: April 4, 2012, 5:30-8:00 PM
Where: Foley Hoag Emerging Enterprise Center, 1000 Winter Street, North Building,
Waltham
Register: http://meg.memberclicks.net/index.php?option=com_mc&view=mc&mcid=
72&eventId=323517&utm_source=Eblast+for+March+30%2C+2012&utm_campaign
=MDG+CC+Eblasts+2012&utm_medium=email
Device development demands precise, reproducible animal models with quantifiable
metrics. They allow for examination of mechanism of action and provide assurance of
safety and insight into efficacy. As device development and innovation accelerate the
challenges and demands on models rise as well. We live in a golden age of inspiration
and development and exciting time for biomedical sciences. The proof of performance
concept, safety and efficacy of emerging technologies is best evaluated in animal
models. Though increasing sophistication in device development, animal medicine,
and model design has provided sophisticated tools but, preclinical model development
still remain a challenge. Accepted models are limited as evolving technology is
extended into multi dimensional and complex therapeutic areas. Quantification of
effect creates further needs with far greater attention paid than ever before to precise
definition of device performance. For all technologies, biological responses must be
evaluated acutely and chronically. Thus, the animal model choice will depend on the
device and the parameters that need to be evaluated.This session will review the
different scenarios for effectively using pre-clinical testing as a basis for getting
regulatory approval for clinical (human) testing. You will hear first-hand experiences
about possible approaches and changes being considered.
WEST's: More Time for You Now
When: Wednesday, April 4, 2012, 6:00-9:00 p.m.
Where: Worcester Polytechnic Institute, Gateway Park Room GP 1002, 60 Prescott
Street, Worcester, MA, 01605
Register: http://www.westorg.org/2012-04-04-more-time-for-you-now
Led by Alesia Latson, author of the book, More Time for You Now, this program
focuses on managing time so that you create work life balance and have more time for
yourself. It also trains you to be much more effective in your job.
Cost: Members- $45; Non-members- $75
Women Making a Difference in Healthcare Innovation When: Thursday, April 5, 2012, 11:45 a.m.-2:00 p.m.
Where: Sargent Hall Suffolk University, 120 Tremont Street, Boston, MA
Registration: www.suffolk.edu/execevents
Panel: Karen Boudreau, MD, FAAFP, SVP, Institute for Healthcare Improvement;
Emily D. Brower, Executive Director, Accountable Care Programs, Atrius Health;
Anne Lang, JD (Suffolk '79), VP of HR and Legal Services, Winchester
Hospital; Somava Stout, MD, VP for Patient-Centered Medical Home Development,
Cambridge Health Alliance
Moderator: Anne Marie Conway, RN (MHA '00), Lecturer of Healthcare
Administration, Suffolk University
Cost: $50 ($25 for Suffolk alumni, faculty, and students). Lunch included.
Is Your Future in Biotech? - Information Session for the Biomedical Laboratory
and Clinical Sciences (BLCS) program When: Thursday, April 5th, 4:00 p.m. - 5:00 p.m.
Where: Boston University Medical Campus, 801 Albany Street, Room 105, Boston
Register: To register, visit www.bu.edu/info
Boston is one of the world's preeminent biomedical centers. Today's rapid pace of innovation
and high demand for qualified professionals present a broad range of opportunities for those
with the right training. That's why it is so critical to learn from the best in the field. Boston
University's Metropolitan College and School of Medicine collaborate in offering the Bachelor
of Science in Biomedical Laboratory & Clinical Sciences-an outstanding academic program
that will prepare you for a rewarding career in biotech.
Study at a top university medical campus, in a biotech hub.
Practice skills sought by innovative companies and start-ups.
Benefit from flexible part- and full-time options to suit your schedule.
For those who already have a foundation in biology, chemistry, and math and who
wish to earn a professional credential, BU's Metropolitan College also offers
certificates in Biotechnology and in Clinical Research.
MedTech Ignite Networking Night When: Thursday, April 5, 2012, 5:00-7:00 p.m.
Where: M2D2 Innovation Hub, 600 Suffolk Street, Lowell
RSVP: [email protected]
MassMEDIC's MedTech IGNITE program will host an evening networking session
for start-up medical device entrepreneurs, advisors, mentors, and board members.
Refreshments and appetizers from 5pm-7pm.
Identifying the right advisory level expertise and uncovering the most innovative
medtech startups is often a daunting challenge. Come network with us and connect
with other experts!
With pointers from:
Mike Travis, principal at Travis & Company, where he was named by BusinessWeek
as one of "The World's Most Influential Headhunters."
MIT Enterprise Forum of Cambridge Presents "Robotics in Healthcare:
Solutions for the Hospital and Home" When: Wednesday, April 9, 2012 (Registration-5:30pm to 6:10pm, Program:-6:10pm-
8:00pm)
Where: MIT Stata Center, Room 32-123, 32 Vassar Street, Cambridge, MA 02139
Pricing: Forum members: $25, Non-members: $45. Students from all universities are
free with college ID. Pre-registration is encouraged at
http://www.mitforumcambridge.org/events/innovation-series-event-robotics-in-
healthcare-solutions-for-the-hospital-and-the-home/
Keynote Speaker: Colin Angle, CEO and Chairman, iRobot
Robotics hold the promise of addressing major healthcare issues in surgery,
diagnostics, prosthetics, physical and mental therapy, monitoring, and support. The
current challenge is for the industry to move beyond the hype cycle and into practical
applications that are used in the hospital, elder and rehabilitative care, and home
environments.
Register
Where are advances being made to personalize care and improve the quality, access
and efficiency of healthcare through robotics? Our keynote speaker will be Colin
Angle, Chairman, CEO and Co-founder of iRobot. Angle's leadership has transformed
the MIT spin-off into a global leader of practical robots. He will share the advances
iRobot is making to develop automated home care and remote presence robots to
address the emerging global need to extend independent living for the aging
population.
WPI - Manufacturing's Evolving Landscape When: April 10, 2012
(5:30-6:30 Networking; 6:30-8:30 Program, elevator pitch, and more networking)
Where: WPI, 100 Institute Road, Worcester, MA, Campus Center Building, 3rd floor
Register: http://www.wpiventureforum.org/registration.html
Today's manufacturing operations could be located anywhere in the world. The
decision to source manufacturing in China requires a thorough analysis of all the pros
and cons. Please join the WPI Venture Forum program on April 10 to hear keynote
speaker Christina Lampe-Önnerud, Ph.D., Founder and International Chairman,
Boston-Power Inc. examine why companies often choose China.
Free Parking: http://www.wpiventureforum.org/directions.html
MIT Enterprise Forum Healthcare & Life Science SIG Event: From Startup
Entrance to Strategic Exit: Building & Realizing Value
When: April 12, 2012 (Registration, Refreshments, and Networking 5:30-6:30PM;
Program 6:30-8:00PM)
Where: UK Trade & Investment, 7th Floor, One Broadway, Cambridge, MA 02142
Register: http://www.mitforumcambridge.org/events/healthcare-life-science-sig-event-
from-startup-entrance-to-strategic-exit-building-realizing-value/
As life science entrepreneurs build value moving from concept to strategy and then
execution, creating a pathway to a potential exit with a strategic partner is challenging,
especially since most of the entrepreneur's energy and focus is on execution and value
creation. Identifying potential corporate acquirers may seem like a simple exercise -
but developing the right awareness and working relationships leading to value-
maximizing partnerships or exits is one of the most difficult aspects of building a new
business. "From Startup Entrance to Strategic Exit" will outline key considerations
and practical tips on the funding perspectives of some strategic corporate concerns and
on the process necessary to build mutual value resulting in a successful exit.
Panelists:
Bill Gruber - President and CEO, Solace Therapeutics (current) - former President &
CEO, Interlace Therapeutics
Tom Umbel - Senior Vice President, Business Development, Hologic Corporation
Val Livada, Ph.D, MALD - Founder, Weybridge Partners and Senior Lecturer at the
Sloane School of Management
Moderator:
Larry Wittenberg, JD - Partner, Co-Chair of Technology & Life Sciences Companies
Major Practice Group, at Goodwin Procter LLP
Propel Careers: Research and Development Career Paths When: Tuesday, April 17, 2012, 5:30-8:00 p.m.
Where: MassBio Offices, Kendall Square, Cambridge
Registration: http://fils42012.eventbrite.com/
Moderator: Lauren Celano, CEO, Propel Careers
Panelists: Kenneth J. Olivier Jr., PhD, Director of Toxicology at Merrimack
Pharmaceuticals; Erin Whalen, PhD, Lab Head and Project Team Leader, Novertis
Institutes for Biomedical Research; Greg McKenzie, PhD, Senior Scientist,
Novophage
ISPE: Documentation Surrounding GMP Facilities and Processes: The Real (and
Sometimes Not-So-Real) Expectations When: April 19, 2012 (Registration and Networking Reception: 5:30 pm to 6:20 pm,
Presentation: 6:20 pm to 8:30 pm)
Where: Royal Sonesta Hotel, Cambridge, MA
Register: http://www.ispeboston.org/events/registration.htm?eventID=183
The Time, Money, Value, Quality, Safety. These variables all describe the amount of
documentation required when specifying, engineering, building, and operating GMP
facilities. This program will investigate and provide open forum discussions on what
each department involved in delivering and operating quality systems for GMP
facilities expects as the minimum documentation requirements and why. In doing so,
we will investigate the blurring lines between commissioning and qualification. We
will also look at the real value that comes from spending countless hours developing,
reviewing, and final approval cycles of the finished document and possible ways to
remediate the process. The program is designed to provide insight to all members of
the delivery and operations team including operations, manufacturing, quality,
validation, and vendors.
PANELISTS:
Chris Ames, Director Quality Assurance Validation, Genzyme .
Rob Beane, Regional Manager - Compliance, IPS (Integrated Project Services)
Mike Marino, Sr. Quality Engineer Corporate Quality Systems, Boston Scientific
Dave Mitchell, Senior QA/QC Lead, Cotter Brothers Corp
REGISTRATION FEES:
Before 04/12/2012:
Members- $50
Non Members-$95
Student Members-$5
After 04/12/2012:
Members-$60
Non Members-$115
Student Members-$10
Join ISPE now and pay the Member rate. Join within one week of this meeting, and
we'll refund you the difference between the Member and Non-Member rate! Contact
the office at (781) 647-4773 or [email protected] for more information.
The Economics of Drug Discovery
When: April 20, 2012, 5:30pm - 7:00pm
Where: Executive Leadership Center Room 412, Boston University School of
Management, 595 Commonwealth Avenue, Boston
Register: http://bit.ly/H5Z30m (Attendance is free, but pre-registration is
required)
Speaker: Dr. Jong Sung Koh (CTO of Genosco)
The pharmaceutical industry is facing unprecedented challenges to its R&D
productivity. Simply stated, without a dramatic increase in R&D productivity, today's
pharmaceutical industry cannot sustain sufficient innovation to replace the loss of
revenues arising from patent expiration of its blockbuster products. So, the key
questions are: when, how and by how much can the R&D productivity be
improved? There will be a discussion of recent strategies in drug discovery and
development to address the long-standing challenges to improving the R&D
productivity. Questions/Sponsorship opportunities: Contact [email protected].
The Effects of Healthcare Reform on Business Models, Price Structure and
Innovation - Challenges and Opportunities Ahead" When: April 26, 7:30-10:30 AM
Where: The office of Mintz Levin in Boston
Website & Registration: http://neibchealthcare.eventbrite.com/
Join the New England-Israel Business Council for an informative "Early Bird"
Networking Breakfast Meeting at the office of Mintz Levin in Boston. Feature speaker
is Richard Siegrist, Chief Innovation Officer at Press Ganey Associates and Associate
Academic Director of Masters in Health Care Management at Harvard School of
Public Health.
2012 WEST's Leadership Awards Event When: Thursday, May 3, 2012, 6:00-9:30 p.m.
Where: Hotel Marlowe, 25 Edwin H. Land Boulevard, Cambridge, MA 02141
Register: http://www.westorg.org/2012-05-03-wests-leadership-awards-
events (Registration Fee: Call 310-996-9435 to receive 20% when you mention this
email!
WEST's fifth-annual Leadership Awards Event and silent auction. This is our
opportunity to acknowledge women who have demonstrated extraordinary leadership
in science and technology.
This year's awardees: Ellen Zane, former President and CEO of Tufts Medical Center,
serves as the Chairperson of the Mass Hospital Association and a director at Parexel,
Pam Reeve, Former founder and CEO of Lightbridge, Chair of the Commonwealth
Institute board, Lead director American Towers, Leanna Caron, SVP and GM of
Sanofis Aventis's Regenerative Medicine Business, WEST Advisory board member,
Canadian and Olympic figure skating judge, Cynthia Gilbert, Technologist and patent
attorney, Founder and CEO of Hyperion Law
Cost: Members- $85; Non-members- $125. Wine, hors d'oeuvres, and a three course
meal will be served.
Activate Networks' 2012 Summit Meeting: Harness the Power of Social
Networks
When: Tuesday, May 8, 2012
Where: Charles Hotel, 1 Bennett Street, Cambridge, MA 02138
Activate Networks proudly presents Summit 2012, the world's leading conference on
leveraging your physician's social networks to drive sales results, Tue., May 8, 2012 at
the Charles Hotel, in Cambridge, Mass. Join us as real leaders discuss how to uncover
and measure real world social networks and leverage social influence for sales
targeting and identifying influential physicians. Space is limited - reserve your seat
now. For more information, visit http://www.activatenetworks.net/summit-2012
USA-India Chamber of Commerce presents its annual: US-India BioPharma &
Healthcare Summit When: Friday, May 11, 2012 at 9:30 a.m.- 7:30 p.m.
Where: President's Ballroom, Hyatt Regency, Cambridge, MA
Registration: www.usaindiachamber.org There is a $900 registration fee.
Join the USA-India Chamber of Commerce as they present its annual US-India
BioPharma & Healthcare Summit. Network with industry leaders, investors,
academicians, and policy makers. The program has the highest concentration of senior
level global BioPharma executives, R&D leaders, Academicians and VCs. Seats are
limited and registration will go up, as the seats fill.
Panel Discussions & Keynotes covering
Drug Discovery and Collaborative Research
Oncology- Science, Research Trends, Investor Perspective and Market
Opportunities
Industry-Academic Research Partnerships
Emerging Markets- Opportunities & Strategies
Funding Innovation, Cross Border Investments and M&A trends in the
BioPharma & Healthcare
Clinical Research, IP, Licensing and Regulatory Issues
R&D Models- Lessons learned for BioPharma
The 2012 ABFO National Conference
When: May 30, 2012, 1:30 PM
Where: Westin Copley Place, Boston
Register: http://www.abfointernational.org/conference.html
On May 30, 2012 at 1:30 p.m., Donna LaVoie will moderate a panel at The
Association of Bioscience Financial Officers 2012 National Conference in Boston.
The panel, titled "Top 10 Burning PR/IR Issues Facing CFOs in Transformative
Times" will address how biotechnology companies have managed through recent
change, and how CFOs should be prepared for the future in overseeing the IR/PR
function.
Participants on the panel include:
Monique Allaire, Director of Investor Relations for AVEO Pharmaceuticals
Bo Piela, Vice President of Corporate Communications for Genzyme
Maria Cantor, Vice President of Investor Relations for Ariad Pharmaceuticals
Grenoble: EuroMedtech 2012 When: May 31- June 1, 2012
Where: Grenoble, France
Registration: http://www.ebdgroup.com/emt/registration/index.php
Join us to the 4th Annual International Medtech Partnering Conference in Grenoble,
France.
You will meet executives from emerging medical technology companies, established
large medtech companies, venture capital, private equity, and institutional financial
firms, distributors and hospitals, and service related companies.
EuroMedtech™ is Europe's leading medical technology partnering conference,
providing collaboration opportunities to medtech decision makers and investors.
EuroMedtech caters to companies involved in all parts of the advanced medical
technology industry, from those serving mainline therapeutic categories such as
orthopedics and cardiovascular, through diagnostics, imaging and eHealth to those
involved in platform technologies such as biomaterials and regenerative medicine.
For more information, visit:
http://www.ebdgroup.com/emt/index.php
MassBioEd Course Schedule Announced: The MassBio Education Foundation has announced their 2012 Courses. To see
the full schedule for the winter and fall and to register, visit
https://secure.massbioed.org/courses/index.php. Course offerings include:
New Course!! Drug Development for the Non-Scientist
One Full Day, Friday May 4, 2012 from 9:00 am to 4:30 pm
NEW Course!! Managing Clinical Trials
6 week program: Thursdays from 5:30-9 pm beginning April 26, 2012 to May
31, 2012
NEW Course!! Investigations & CAPA
Full Day, Tuesday April 10, 2012, 9 am to 4:30 pm MassBio Offices
BioBasics: Biotech for the Non-Scientist, Winter 2012
Thursday & Friday February 9 & 10, 2011 from 9 am to 4:30 pm
Biotechnology Project Management, Spring 2012 Intensive
Six Weeks on Wednesday Evenings from 5:30 pm - 9:00 pm, beginning April
4th- through May 9th , 2012
Improving Biotech Presentation Skills: Spring 2012
Two-full days: Wednesdays, May 16th & June 13, 2012, 9:00 am - 5:00 pm
Leadership Training Program for Scientists, Managers, and Support Services:
Spring 2012
Two full days: Wednesdays April 4th and May 2nd, 2012, 9:00 am -5:00 pm
9th Annual Community College Program Day When: June 18, 2012 7:30 a.m.- 5:00 p.m.
Where: The Westin Waterfront Boston Hotel, 425 Summer Street, Boston, MA
02210
Registration:
http://www.regonline.com/Register/Checkin.aspx?EventID=1061901
This ninth annual BIO-associated day-long event features perspectives on
biotechnology education, training and the workforce from community college
educators and their industry partners plus a time to network with
colleagues. Organized with the help of BIO by the NBC2, Bio-Link, and NCB
W
Register online by credit card for the $150 fee per person. There will be no on
site registration. Price includes continental breakfast and delicious buffet
lunch.
MIT Professional Education Short Programs: 2012 Biotechnology /
Pharmaceutical courses for professionals These 2-5 days courses are taught on the MIT campus by MIT faculty /
researchers and experts from industry and academia
Offerings include:
Flow Chemistry: Continuous Synthesis and Purification of Pharmaceuticals
and Fine Chemicals - June 25-27, 2012
Formulation and Stabilization of Biotherapeutics - July 9-11, 2012
Controlled Release Technology: Polymeric Delivery Systems for
Pharmaceuticals, Proteins, and Other Agents - July 9-13, 2012
Nanomaterials for Biological and Pharmaceutical Technologies - July 16-20,
2012
Fermentation Technology - July 30- August 3, 2012
Downstream Processing - August 6-10, 2012
Full schedule & details: http://web.mit.edu/professional/short-
programs/courses_topic.html
TUFTS CSDD's Leadership for Drug Development Teams When: July 10-11, 2012
Where: Nine Zero Hotel, 90 Tremont Street, Boston, MA 02108
Registration: http://csdd.tufts.edu/courses/leadership_course
Who should attend: Team leaders, program managers, functional directors and
scientists form across the industry looking to build leadership skills for cross-
functional R&D.
This fast-paced two-day workshop brings together team leaders, program
managers, functional directors and scientists from across the industry to build
leadership skills for cross-functional R&D efforts. Created specifically for
pharmaceutical professionals, this highly interactive, case-based program
teaches you how to lead multi-disciplinary teams to collaborate effectively in
face of the increasingly complex challenges of life science innovation.
Early-bird registration rates are available and space is limited to 35
seats. Contact Jonathan Hsieh at [email protected] or 617-636-0840
for more information.
Harvard University Office of Technology Development and Speid &
Associates Presents: Drug Development Boot Camp When: November 14-15, 2012
Where: The Harvard Club, Boston, MA
Registration: Early Bird Registration- $2,050 if paid by March 15, 2012
if paid by June 15, 2012- $2,650
if paid by October 17, 2012- $2,930
if paid after October 18, 2012- $3,430
An intense two day course for Biotech, Pharma Executives, and Harvard
University Investigators.
What Will You Learn?
Spending many years and huge sums of money developing a drug or drugs that
the market does not want, and will not pay for. Making costly mistakes
throughout the development process, which will ultimately cost the company,
one's reputation and may even lead to safety problems in those administered
the company's products. Clinical hold situations which are extremely costly.
Inability to raise funds or to find an appropriate exit.
Register Now - Space is Limited! -
www.drugstomarket.com/harvarddrugbootcamp/
Forward email
This email was sent to [email protected] by [email protected] | Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.
Massachusetts Life Sciences Center | 1000 Winter Street, Suite 2900 | Waltham | MA | 02454